Bunavail FDA Approval History
FDA Approved: Yes (Discontinued) (First approved June 6, 2014)
Brand name: Bunavail
Generic name: buprenorphine and naloxone
Dosage form: Buccal Film
Company: BioDelivery Sciences International, Inc.
Treatment for: Opiate Dependence
Bunavail (buprenorphine and naloxone) buccal film is an opioid analgesic/opioid antagonist formulation for the maintenance treatment of opioid dependence.
Development Timeline for Bunavail
|Jun 9, 2014||FDA Approves Bunavail Buccal Film for the Maintenance Treatment of Opioid Dependence|
|Oct 14, 2013||BioDelivery Sciences Announces FDA Acceptance of Bunavail NDA for Filing|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.